Cambiar Investors’s Phibro Animal Health PAHC Stock Holding History

Cambiar Investors’s Portfolio PAHC Stock Details PAHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-87,282	Closed	-$2.77M	–	158
2019 Q2	$2.77M	Sell	87,282 -15,626	-15%	-$490K	0.07%	96
2019 Q1	$3.4M	Buy	102,908 +44,000	+75%	+$1.37M	0.08%	95
2018 Q4	$1.89M	Buy	+58,908	New	+$2.22M	0.04%	149

Other funds holding PAHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CSC

Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return

FIM

Foresters Investment Management New York $5.05B AUM 5.06% 1-Year Est. Return

Cambiar Investors's PAHC Position: Q3 2019 in Review

Cambiar Investors sold out of Phibro Animal Health (PAHC) in Q3 2019, closing a stake of 87,282 shares — an estimated $2.77M sold.

Cambiar Investors first reported a position in PAHC in Q4 2018 and held it in 3 quarters. The position peaked at $3.4M in Q1 2019. 153 funds tracked by Wall St. Rank hold PAHC as of Q3 2019.

Cambiar Investors reported no remaining Phibro Animal Health position as of Q3 2019 after selling out during the quarter.
Cambiar Investors sold 87,282 Phibro Animal Health shares in Q3 2019, an estimated $2.77M.
Cambiar Investors first reported a position in Phibro Animal Health in Q4 2018 and held it in 3 quarters.
Cambiar Investors's Phibro Animal Health position peaked at $3.4M in Q1 2019.
153 funds tracked by Wall St. Rank held Phibro Animal Health as of Q3 2019.

Based on Cambiar Investors's 13F filing for Q3 2019, filed 17 Oct 2019.